HLB Co., Ltd. (KOSDAQ:028300)
South Korea · Delayed Price · Currency is KRW 60,800
-2,200 (-3.49%)
Apr 30, 2026, 3:30 PM KST
HLB Co., Ltd. Market Cap
HLB Co., Ltd. has a market cap or net worth of 8.08 trillion as of April 30, 2026. Its market cap has increased by 8.08% in one year.
Market Cap
8.08T
Enterprise Value
8.43T
Revenue
84.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
60,800.00
Market Cap Chart
Since December 24, 2008, HLB Co., Ltd.'s market cap has increased from 13.46B to 8.08T, an increase of 59,935.49%. That is a compound annual growth rate of 44.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 8.37T | 25.25% |
| Dec 30, 2025 | 6.69T | -30.26% |
| Dec 30, 2024 | 9.59T | 46.53% |
| Dec 28, 2023 | 6.54T | 98.02% |
| Dec 29, 2022 | 3.30T | -10.84% |
| Dec 30, 2021 | 3.71T | -24.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 20.33T |
| Samsung Epis Holdings | 13.91T |
| Kolon TissueGene | 9.10T |
| SK Biopharmaceuticals | 7.97T |
| LigaChem Biosciences | 6.76T |
| Peptron | 6.30T |
| Voronoi | 5.33T |
| OliX Pharmaceuticals | 3.75T |